Effective June 13, 2019, the board of directors of Verrica Pharmaceuticals Inc. appointed Craig Ballaron to serve as a director of the Company. Mr. Ballaron will serve as a Class II director whose term will expire at the 2020 annual meeting of stockholders. Additionally, Mr. Ballaron was appointed as a member of the Company's Compensation and Nominating and Corporate Governance Committees, also effective June 13, 2019, thereby increasing the number of members serving on both the Compensation and Nominating and Corporate Governance Committees from two to three. Craig Ballaron, age 58, has served as an independent consultant in the pharmaceuticals, cosmeceuticals, physician dispense products and electronics fields since 2016.